No Detail Found!

Drug Resistance in Mycobacterium tuberculosis Isolated from a Group of Patients Referred to PMRC Research Centre at Mayo Hospital, Lahore, Pakistan

Author(s)
Muhammad Idrees National Centre ofExcellence in Molecular Biology, Canal Bank Road, Thokar Niaz Baig, Lahore-53700, University of the Punjab, Pakistan (Ml, SR) and Pakistan Medical Research Council, King Edward Medical College,·Mayo Hospital, Lahore, Pakistan
Aftab H. Bhatti National Centre ofExcellence in Molecular Biology, Canal Bank Road, Thokar Niaz Baig, Lahore-53700, University of the Punjab, Pakistan (Ml, SR) and Pakistan Medical Research Council, King Edward Medical College,·Mayo Hospital, Lahore, Pakistan
Saulat Ullah Khan National Centre ofExcellence in Molecular Biology, Canal Bank Road, Thokar Niaz Baig, Lahore-53700, University of the Punjab, Pakistan (Ml, SR) and Pakistan Medical Research Council, King Edward Medical College,·Mayo Hospital, Lahore, Pakistan
S. Riazuddin National Centre ofExcellence in Molecular Biology, Canal Bank Road, Thokar Niaz Baig, Lahore-53700, University of the Punjab, Pakistan (Ml, SR) and Pakistan Medical Research Council, King Edward Medical College,·Mayo Hospital, Lahore, Pakistan
Abstract
Drug susceptibility testing was done on positive cultures of 144 tubercular patients with eight commonly used anti-tuberculosis drugs i.e. isoniazid (INH), streptomycin (STM), Para-aminosalicyclic acid (PAS), Ethanamide (ETH), Ethaplbutol (ETB), Thiacitazon (THI), Rifampicin (RIM), and Pyrazinamide (PZA). One hundred and six (73.61%) of the isolates were resistant to one or more anti-tuberculosis drugs. Of 106 resistant patients, 36 (24.3%) were resistant to only one anti-tuberculosis drug, while 71 (49.3%) were multiple drug resistance cases. As regards resistance to individual drugs, 42 (29.16%) of the isolates were resistant to INH, 31 (21.62%) to STM, 86 (59.72%) to PAS, 28 (19.44%) to ETH, 28 (19.44%) to ETB, 25 (17.36%) to THI, 31 (21.62%) to RIM and 48 (33.33%) to PZA. To prevent Mycobacterium tuberculosis to acquire resistance against anti-tuberculosis drugs, patients with active tuberculosis must be identified quickly by rapid diagnostic tests such as PCR, and must be treated with full and appropriate regimens of anti-tuberculosis drugs. ·
Publication Details
Page(s) 335-339
DOI DOI not available
Published Journal: Pakistan Journal of Zoology, Volume: 30, Issue: 4, Year: 1998

Request the full text from PASTIC

Keywords
multi-drug resistance, Mycobacterium tuberculosis, Tuberculosis, anti-tuberculosis drugs
0

Citations

0

Downloads

82

Views